Opendata, web and dolomites


ImmunoPET directed to specific subtypes of GABAA receptors as strategy for molecular mapping of behaviour and mental illness

Total Cost €


EC-Contrib. €






 GABARPET project word cloud

Explore the words cloud of the GABARPET project. It provides you a very rough idea of what is the project "GABARPET" about.

immunopet    invasive    reveals    lack    subunits    schizophrenia    expression    mental    changes    89zr    papers    gabaa    insights    disease    clear    chain    immune    reveal    nevertheless    positron    suggested    recombinant    sensitive    peripheral    severe    molecular    limited    transmigrate    healthy    bbb    gabaergic    antibodies    18f    vivo    sense    biomarkers    characterization    quantitative    knockout    neuroimage    setting    abnormalities    models    additional    fragment    di    alpha    receptors    probes    blood    tracers    radionuclides    unveil    phenotype    specificity    neurological    brain    postmortem    affinity    shed    differential    effect    construct    single    injection    pet    society    patients    wild    receptor    bispecific    disorder    conventional    small    tomography    gaba    scfv    directed    rodent    diseases    individuals    penetrate    profound    mice    transferrin    psychiatric    surface    light    intact    diagnosis    gabarpet    mostly    barrier    emission    readily    antibody    cell    wants    cyclotron    tap    labeled    imaging    hallmarks   

Project "GABARPET" data sheet

The following table provides information about the project.


Organization address
city: Turku
postcode: 20014

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 304˙021 €
 EC max contribution 304˙021 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-CAR
 Starting year 2020
 Duration (year-month-day) from 2020-09-01   to  2023-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TURUN YLIOPISTO FI (Turku) coordinator 304˙021.00


 Project objective

Changes in GABA receptors are known hallmarks for numerous neurological diseases including schizophrenia which is a severe psychiatric disorder that has a profound effect on both the individuals affected and society. The diagnosis of schizophrenia is complex because of the loss of high specific biomarkers. Research papers have suggested that the differential expression of GABAA receptors in the brain is associated with this mental disease. The current evidence on GABAergic abnormalities in schizophrenia is mostly based on postmortem studies and, in this sense, in vivo measurements of GABAA receptor subunits can reveal additional insights. This project will develop Positron Emission Tomography (PET) probes which could unveil quantitative information about GABAA receptor expression in schizophrenia patients. However, the lack of imaging tracers with high affinity and specificity do not shed a clear light on the diagnosis in a traditional PET setting. In this sense, the immune-positron emission tomography (immunoPET) is a non-invasive technology based in antibody imaging which reveals a specific and sensitive molecular characterization of the cell surface phenotype in vivo. Nevertheless, its success in neuroimage is limited because of intact antibodies cannot penetrate the Brain Blood Barrier (BBB) in healthy conditions. However, GABARPET will tap into a small recombinant bispecific antibody construct targeting the GABAA receptors as well as the transferrin receptor because it is able to readily transmigrate across the BBB in vivo after peripheral injection. This project wants to develop di-single-chain variable fragment (di-scFv) directed to α1 and α2 subunits of GABAA receptors. Then, they will be labeled with conventional radionuclides produced by cyclotron as 18F and 89Zr. ImmunoPET probes will be used in wild-type mice, GABAA receptor knockout mice and different kind of rodent models of schizophrenia.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GABARPET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GABARPET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Language Use (2019)

Languages and Language Use

Read More  

CO2COFs (2019)

New Heterogeneous Catalyst Materials for Hydrogenation of CO2 to Formic Acid: Metallophthalocyanine-Based 2D- and 3D Covalent Organic Frameworks

Read More  

pyrroQuin (2020)

Synthesis and Biological Evaluation of Pyrroquinoline Pseudo-Natural Products

Read More